EDC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.790400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.993800E-01
Normal-vs-Stage2
2.637800E-01
Normal-vs-Stage3
1.371250E-01
Normal-vs-Stage4
5.502800E-01
Stage1-vs-Stage2
2.094800E-01
Stage1-vs-Stage3
2.088200E-01
Stage1-vs-Stage4
6.415800E-01
Stage2-vs-Stage3
2.073000E-01
Stage2-vs-Stage4
8.622400E-01
Stage3-vs-Stage4
4.467200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.097000E-01
Normal-vs-AfricanAmerican
1.712550E-01
Normal-vs-Asian
1.779570E-01
Caucasian-vs-AfricanAmerican
9.312200E-01
Caucasian-vs-Asian
4.468800E-01
AfricanAmerican-vs-Asian
5.200600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.107000E-01
Normal-vs-Female
3.871200E-01
Male-vs-Female
2.466800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.435400E-01
Normal-vs-Age(41-60Yrs)
5.478200E-01
Normal-vs-Age(61-80Yrs)
1.438180E-01
Normal-vs-Age(81-100Yrs)
3.899600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.296220E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.813950E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.702010E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.957480E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.289400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.919400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.351410E-01
Normal-vs-Daily Drinker
1.275610E-01
Normal-vs-Weekly Drinker
5.388800E-01
Normal-vs-Occasional Drinker
4.246000E-01
Normal-vs-Social Drinker
3.566200E-01
Non Drinker-vs-Daily Drinker
9.255400E-01
Non Drinker-vs-Weekly Drinker
3.087600E-01
Non Drinker-vs-Occasional Drinker
1.874150E-01
Non Drinker-vs-Social Drinker
2.895000E-01
Daily Drinker-vs-Weekly Drinker
3.636000E-01
Daily Drinker-vs-Occasional Drinker
2.284000E-01
Daily Drinker-vs-Social Drinker
3.333000E-01
Weekly Drinker-vs-Occasional Drinker
9.573200E-01
Weekly Drinker-vs-Social Drinker
9.244600E-01
Occasional Drinker-vs-Social Drinker
8.532200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.939000E-01
Normal-vs-Grade 2
9.049400E-01
Normal-vs-Grade 3
9.404800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.025400E-01
Grade 1-vs-Grade 3
3.357400E-01
Grade 1-vs-Grade 4
8.939000E-01
Grade 2-vs-Grade 3
2.358800E-01
Grade 2-vs-Grade 4
9.049400E-01
Grade 3-vs-Grade 4
9.404800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.141600E-02
Normal-vs-NonDiabetic
3.182200E-01
Diabetic-vs-NonDiabetic
2.815800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.410400E-01
Normal-vs-NoPancreatitis
2.412600E-01
Pancreatitis-vs-NoPancreatitis
2.808800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.061200E-01
Normal-vs-N1
2.916600E-01
N0-vs-N1
6.642600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.037000E-01
Normal-vs-TP53-NonMutant
4.110600E-01
TP53-Mutant-vs-TP53-NonMutant
2.894400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
